Carmine Fedele

2.0k total citations
16 papers, 870 citations indexed

About

Carmine Fedele is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Carmine Fedele has authored 16 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Immunology and Allergy and 6 papers in Oncology. Recurrent topics in Carmine Fedele's work include Cell Adhesion Molecules Research (7 papers), Extracellular vesicles in disease (5 papers) and HER2/EGFR in Cancer Research (5 papers). Carmine Fedele is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Extracellular vesicles in disease (5 papers) and HER2/EGFR in Cancer Research (5 papers). Carmine Fedele collaborates with scholars based in United States, Italy and United Kingdom. Carmine Fedele's co-authors include Lucia R. Languino, Amrita Singh, Renato V. Iozzo, Brad J. Zerlanko, Huimin Lu, Benjamin G. Neel, James H. Keen, Marja T. Nevalainen, George Miller and Uğur Özerdem and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Carmine Fedele

15 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmine Fedele United States 12 628 280 214 178 148 16 870
Tetsuji Sawada Japan 20 494 0.8× 392 1.4× 199 0.9× 58 0.3× 220 1.5× 38 928
Hillary J. Millar United States 9 483 0.8× 356 1.3× 150 0.7× 89 0.5× 246 1.7× 14 773
Karmele Valencia Spain 16 445 0.7× 265 0.9× 310 1.4× 83 0.5× 106 0.7× 29 775
Michelle Hymowitz United States 7 305 0.5× 306 1.1× 327 1.5× 79 0.4× 112 0.8× 7 604
Dongyin Yu United States 7 498 0.8× 194 0.7× 151 0.7× 30 0.2× 57 0.4× 9 685
Iker Antón Spain 9 305 0.5× 225 0.8× 214 1.0× 76 0.4× 49 0.3× 15 538
Benjamin Caleb United States 7 526 0.8× 232 0.8× 149 0.7× 121 0.7× 45 0.3× 8 827
Maher N. Younes United States 19 517 0.8× 498 1.8× 169 0.8× 83 0.5× 62 0.4× 21 1.1k
Neel I. Nissen Denmark 11 202 0.3× 280 1.0× 132 0.6× 112 0.6× 89 0.6× 18 600

Countries citing papers authored by Carmine Fedele

Since Specialization
Citations

This map shows the geographic impact of Carmine Fedele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Fedele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Fedele more than expected).

Fields of papers citing papers by Carmine Fedele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmine Fedele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Fedele. The network helps show where Carmine Fedele may publish in the future.

Co-authorship network of co-authors of Carmine Fedele

This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Fedele. A scholar is included among the top collaborators of Carmine Fedele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Fedele. Carmine Fedele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Teng, Kai Wen, Takamitsu Hattori, Carmine Fedele, et al.. (2021). Selective and noncovalent targeting of RAS mutants for inhibition and degradation. Nature Communications. 12(1). 2656–2656. 58 indexed citations
2.
Fedele, Carmine, Hao Ran, Brian Diskin, et al.. (2018). SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models. Cancer Discovery. 8(10). 1237–1249. 210 indexed citations
3.
Krishn, Shiv Ram, Amrita Singh, Carmine Fedele, et al.. (2018). Prostate cancer sheds the αvβ3 integrin in vivo through exosomes. Matrix Biology. 77. 41–57. 85 indexed citations
4.
Lu, Huimin, Tao Wang, Jing Li, et al.. (2016). αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor. Cancer Research. 76(17). 5163–5174. 27 indexed citations
5.
Singh, Amrita, Carmine Fedele, Huimin Lu, et al.. (2016). Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype. Molecular Cancer Research. 14(11). 1136–1146. 121 indexed citations
6.
Fedele, Carmine, Amrita Singh, Brad J. Zerlanko, Renato V. Iozzo, & Lucia R. Languino. (2015). The αvβ6 Integrin Is Transferred Intercellularly via Exosomes. Journal of Biological Chemistry. 290(8). 4545–4551. 146 indexed citations
7.
Dutta, Anindita, Jing Li, Carmine Fedele, et al.. (2015). αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression. Biochemical Journal. 466(3). 525–536. 22 indexed citations
8.
Trerotola, Marco, Kirat Kumar Ganguly, Ladan Fazli, et al.. (2015). Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts. Oncotarget. 6(16). 14318–14328. 55 indexed citations
9.
Singh, Amrita, Carmine Fedele, Renato V. Iozzo, & Lucia R. Languino. (2015). Abstract 357: Exosome-mediated transfer of alphaV integrins promotes prostate cancer cell-cell communication. Cancer Research. 75(15_Supplement). 357–357. 1 indexed citations
10.
Sayeed, Aejaz, Carmine Fedele, Marco Trerotola, Kirat Kumar Ganguly, & Lucia R. Languino. (2013). IGF-IR Promotes Prostate Cancer Growth by Stabilizing α5β1 Integrin Protein Levels. PLoS ONE. 8(10). e76513–e76513. 30 indexed citations
11.
Fedele, Carmine, Sílvia Carvalho, Gennaro Riccio, et al.. (2013). Effects of a human compact anti-ErbB2 antibody on gastric cancer. Gastric Cancer. 17(1). 107–115. 6 indexed citations
12.
Fedele, Carmine, et al.. (2012). Mechanisms of cardiotoxicity associated with ErbB2 inhibitors. Breast Cancer Research and Treatment. 134(2). 595–602. 51 indexed citations
13.
Fedele, Carmine, Gennaro Riccio, Carmela Coppola, et al.. (2011). Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. Breast Cancer Research and Treatment. 133(2). 511–521. 43 indexed citations
14.
Troise, Fulvia, Maria Monti, Antonello Merlino, et al.. (2011). A novel ErbB2 epitope targeted by human antitumor immunoagents. FEBS Journal. 278(7). 1156–1166. 12 indexed citations
15.
Lorenzo, Claudia De, Gennaro Riccio, Carmine Fedele, et al.. (2010). Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents.. Journal of Clinical Oncology. 28(15_suppl). e11054–e11054. 3 indexed citations
16.
Círillo, Massimo, et al.. (2009). Is anaemia a correct indication to colonoscopy in elderly patients?. BMC Geriatrics. 9(S1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026